Maven Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,500
Closed -$1.34M 633
2025
Q2
$1.34M Buy
+2,500
New +$1.2M 0.03% 381
2024
Q4
Sell
-1,700
Closed -$859K 916
2024
Q3
$859K Sell
1,700
-2,200
-56% -$1.07M 0.02% 537
2024
Q2
$1.9M Buy
+3,900
New +$1.96M 0.04% 381
2023
Q4
Sell
-3,700
Closed -$1.62M 1051
2023
Q3
$1.62M Buy
+3,700
New +$1.85M 0.02% 464
2023
Q2
Sell
-400
Closed -$200K 955
2023
Q1
$200K Buy
+400
New +$191K ﹤0.01% 884
2022
Q3
Sell
-1,100
Closed -$386K 1159
2022
Q2
$386K Sell
1,100
-100
-8% -$40.8K 0.01% 670
2022
Q1
$656K Sell
1,200
-200
-14% -$105K 0.02% 457
2021
Q4
$922K Sell
1,400
-1,500
-52% -$942K 0.03% 376
2021
Q3
$1.8M Hold
2,900
0.06% 271
2021
Q2
$1.83M Buy
2,900
+700
+32% +$387K 0.07% 259
2021
Q1
$1.08M Buy
+2,200
New +$1.1M 0.05% 383
2020
Q4
Sell
-3,000
Closed -$1.18M 687
2020
Q3
$1.18M Hold
3,000
0.1% 207
2020
Q2
$990K Buy
3,000
+1,700
+131% +$492K 0.07% 215
2020
Q1
$315K Buy
+1,300
New +$339K 0.04% 221

Other funds holding IDXX

Maven Securities's IDXX Position: Q4 2024 in Review

Maven Securities sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 748 shares — an estimated $378K sold.

Maven Securities first reported a position in IDXX in Q1 2020 and held it in 8 quarters. The position peaked at $515K in Q2 2024. 1,123 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Maven Securities reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Maven Securities sold 748 Idexx Laboratories shares in Q4 2024, an estimated $378K.
  • Maven Securities first reported a position in Idexx Laboratories in Q1 2020 and held it in 8 quarters.
  • Maven Securities's Idexx Laboratories position peaked at $515K in Q2 2024.
  • 1,123 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Maven Securities's 13F filing for Q4 2024, filed 14 Feb 2025.